INDmoney
Allogene Therapeutics, Inc. Stock Performance
as on January 21, 2026 at 8:40 pm IST
Day's Low
Day's High
$1.55$1.57
0.64%
Downside
0.64%
Upside
52 Week's Low
52 Week's High
$0.86$3.7844.74%
Downside
142.31%
Upside
Allogene Therapeutics, Inc. share price movements today
- Previous Close
- $1.57
- Open
- $1.57
- Volume
- 278.7K
- Day's Low - High
- $1.55 - $1.57
- 52 Week Low - High
- $0.86 - $3.78
Allogene Therapeutics, Inc. Historical Returns
- 1 Month Return
- + 14.79 %
- 3 Month Return
- + 29.37 %
- 1 Year Return
- -11.41 %
- 3 Year Return
- -75.11 %
- 5 Year Return
- -94.8 %
Allogene Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Allogene Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$366.3M
EPS (TTM)
-0.9163
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.97
Industry PE ratio
-1.6651931330472103
PEG Ratio
0EBITDA
-212.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-54.43%
Allogene Therapeutics, Inc. Stock Valuation
Track how Allogene Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Allogene Therapeutics, Inc. in the last 5 years
Lowest (-18.43x)
March 31, 2021
Today (-1.97x)
January 21, 2026
Industry (-1.67x)
January 21, 2026
Highest (-1.20x)
June 30, 2025
Today’s Price to Earnings Ratio: -1.97x
Allogene Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Allogene Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $366.3M | -94.8% | -1.97 | 0.00% | |
| BUY | $47.4B | 113.21% | 1237.91 | 1.36% | |
| BUY | $113.2B | 85.25% | 31.06 | 31.35% | |
| NA | $37.4B | NA | 663.12 | 1.38% | |
| BUY | $77.7B | 37.03% | 17.57 | 32.13% |
Stock Returns calculator for Allogene Therapeutics, Inc. Stock including INR - Dollar returns
The Allogene Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Allogene Therapeutics, Inc. investment value today
Current value as on today
₹90,816
Returns
Returns from Allogene Therapeutics, Inc. Stock
Dollar Returns*
₹6,033 (+6.03%)
Analyst Recommendation on Allogene Therapeutics, Inc. Stock
Based on 23 analysts
73.91%
Buy
26.09%
Hold
0.00%
Sell
Based on 23 analysts, 73.91% of analysts recommend a 'BUY' rating for Allogene Therapeutics, Inc.. Average target price of $7.38
Allogene Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Allogene Therapeutics, Inc..
What analysts predicted
78.86%UPSIDE
Target Price
$7.38
Current Price
$1.56
Analyzed by
23 Analysts
Target
$7.38
Allogene Therapeutics, Inc. target price $7.38, a slight upside of 78.86% compared to current price of $1.56. According to 23 analysts rating.
Allogene Therapeutics, Inc. Stock’s Investor Sentiment and Interest
Search interest for Allogene Therapeutics, Inc. Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:133% versus previous 30 day period
Allogene Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Allogene Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Allogene Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Allogene Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Allogene Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 6 quarters, -66.35M → -41.4M (in $), with an average increase of 10.3% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, ALLO stock has moved up by 14.8%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.5% return, outperforming this stock by 100.6%
- NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 52.8% return, outperforming this stock by 64.2%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 22.0K → -22.0K (in $), with an average decrease of 200.0% per quarter
About Allogene Therapeutics, Inc.
| Organisation | Allogene Therapeutics, Inc. |
| Headquarters | 210 East Grand Avenue, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Dr. David D. Chang M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Allogene Therapeutics, Inc.
Name | Title |
|---|---|
Dr. Arie S. Belldegrun F.A.C.S., M.D. | Co-Founder & Executive Chairman |
Dr. Zachary J. Roberts M.D., Ph.D. | Executive VP of Research & Development and Chief Medical Officer |
Mr. Benjamin M. Beneski | Senior VP & Chief Technical Officer |
Ms. Susan R. Lundeen | Chief People Officer |
Ms. Christine Cassiano | Executive VP, Chief Corporate Affairs & Brand Strategy Officer |
Dr. David D. Chang M.D., Ph.D. | Co-Founder, President, CEO & Director |
Mr. Joshua A. Kazam | Co-Founder & Director |
Mr. Geoffrey M. Parker | Executive VP & CFO |
Mr. Earl M. Douglas Esq. | Senior VP, General Counsel, Compliance Officer & Corporate Secretary |
Ms. Annie Yoshiyama | SVP & Corporate Controller |
FAQs
What is Allogene Therapeutics, Inc. share price today?
Allogene Therapeutics, Inc. share price today is $1.56 as on . Allogene Therapeutics, Inc. share today touched a day high of $1.57 and a low of $1.55.
What is the 52 week high and 52 week low for Allogene Therapeutics, Inc. share?
Allogene Therapeutics, Inc. share touched a 52 week high of $3.78 on and a 52 week low of $0.86 on . Allogene Therapeutics, Inc. stock price today i.e. is trending at $1.56,which is 58.73% down from its 52 week high and 80.95% up from its 52 week low.
What is Allogene Therapeutics, Inc.'s market capitalisation today?
Allogene Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Allogene Therapeutics, Inc. Stock (ALLO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Allogene Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Allogene Therapeutics, Inc. Shares that will get you 0.9615 shares as per Allogene Therapeutics, Inc. share price of $1.56 per share as on January 21, 2026 at 8:40 pm IST.
What is the minimum amount required to buy Allogene Therapeutics, Inc. Stock (ALLO) from India?
Indian investors can start investing in Allogene Therapeutics, Inc. (ALLO) shares with as little as ₹91.673 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Allogene Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Allogene Therapeutics, Inc. share’s latest price of $1.56 as on January 21, 2026 at 8:40 pm IST, you will get 6.4103 shares of Allogene Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Allogene Therapeutics, Inc. has given to Indian investors in the last 5 years?
Allogene Therapeutics, Inc. stock has given -94.8% share price returns and 24.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?